Qutoutiao, a Chinese news aggregator app that seeks to differentiate itself from market leader Jinri Toutiao by focusing on entertainment-oriented content, has announced plans to list in the US.
The company was established as recently as 2016 but it has already achieved unicorn status, with Tencent Holdings leading a $200 million Series B round in March at a valuation of $1.6 billion. Shunwei...
Suzhou Medilink Therapeutics, a Chinese biotech company specializing in antibody-drug conjugates (ADCs) commonly used as targeted therapies for treating cancer, has raised $50 million in Series A funding across two tranches.
OrbiMed has closed its latest Asia life sciences fund, which primarily invests in China and India, with $800 million in commitments.
Tuya, a Chinese software platform for internet-of-things (IoT) systems that mainly offers platform-as-a-service (PaaS) products is pursuing a US IPO.